PROEHL GERALD T → Dermata Therapeutics, Inc. DRMAW

Stake: 15.00% Shares: 803,751 CUSIP: 249845108 Class: Common Stock, Par Value $0.0001 Per Share.

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Filer track record (4 filings): 0% 90d win rate, +0.0% 90d edge
High conviction ownership stake (15.0%)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-08-14

DTC 1.00

401 shares short · -16.5% vs prior

Post-Filing Returns · since 2025-01-24 on DRMAW

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

0.0%

+90 days

0.0%

+180 days

0.0%

Anchor price 0.02 on closest trading day on/after 2025-01-24. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Dermata Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2026-06-01	SCHEDULE 13D	Van Hoose Kyri K.	9.00%	384,352	view →
2026-01-08	SCHEDULE	PROEHL GERALD T	24.70%	694,530	view →
2025-04-03	SCHEDULE	PROEHL GERALD T	7.80%	804,098	view →
2025-01-23	SCHEDULE	PROEHL GERALD T	16.00%	803,751	view →

Other Filings by PROEHL GERALD T

Filed	Form	Issuer	Stake	Shares
2026-01-08	SCHEDULE	Dermata Therapeutics, Inc. DRMAW	24.70%	694,530	view →
2025-04-03	SCHEDULE	Dermata Therapeutics, Inc. DRMAW	7.80%	804,098	view →
2025-01-23	SCHEDULE	Dermata Therapeutics, Inc. DRMAW	16.00%	803,751	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →